Violation of Treatment Guidelines -- Hazard for Rectal Cancer Patients

Overview

Journal Int J Colorectal Dis

Specialties Gastroenterology
General Surgery

Date 2011 Aug 24

PMID 21861073

Citations 6

Authors

Eivind Jullumstro

Arne Wibe

Stian Lydersen

Tom-Harald Edna

Affiliations

Soon will be listed here.

Abstract

Aim: The aim of this study was to evaluate temporal trends in treatment and outcome in rectal cancer diagnosed during 1980-2004 at Levanger Hospital.

Materials And Methods: A protocol for prospective registration of rectal cancer treated with total mesorectal excision including operative strategy, radiotherapy and surveillance was established at Levanger Hospital in 1980. In this study, all rectal cancer patients treated during 1980-2004 were included.

Results: More patients received preoperative radiotherapy during 2000-2004, but otherwise there were no significant differences in presentation or treatment during 1980-2004. The 5-year local recurrence rate after resection with curative intent was 4.5% (0-9.7), 18.7% (10.3-27.1) and 2.2% (0-6.7) in 1980-1989, 1990-1999 and 2000-2004 (p = 0.006), respectively. Out of a total of 23 cases of local recurrence, treatment guidelines, mainly with regard to radiotherapy, were violated in 19 cases. The 5-year overall survival after resection with curative intent was 65% (95% confidence interval [CI] 55-76) during 1980-1989, 58% (49-68) in 1990-1999 and 71% (59-83) in 2000-2004 (n.s). The 5-year relative survival was 83% (95% CI 69-95) during 1980-1989, 71% (59-81) in 1990-1999 and 84% (69-98) in 2000-2004 (n.s).

Conclusion: Rectal cancer patients experienced excellent outcomes in the period 1980-1989 and 2000-2004. Due to violations of treatment guidelines, the rate of local recurrence was much too high in the period 1990-1999. This article illustrates the importance of continuous quality assurance in the treatment of rectal cancer to maintain optimized outcomes for the patients.

Citing Articles

Quality improvements in radiation oncology clinical trials.

Smith K, Ulin K, Knopp M, Kry S, Xiao Y, Rosen M Front Oncol. 2023; 13:1015596.

PMID: 36776318 PMC: 9911211. DOI: 10.3389/fonc.2023.1015596.

Quality assurance in radiation oncology.

Fitzgerald T, Followill D, Laurie F, Boterberg T, Hanusik R, Kessel S Pediatr Blood Cancer. 2021; 68 Suppl 2:e28609.

PMID: 33818891 PMC: 10578132. DOI: 10.1002/pbc.28609.

Impact of a multidisciplinary training programme on outcome of upper rectal cancer by critical appraisal of the extent of mesorectal excision with postoperative MRI.

Bondeven P, Laurberg S, Hagemann-Madsen R, Pedersen B BJS Open. 2020; 4(2):274-283.

PMID: 32207568 PMC: 7093769. DOI: 10.1002/bjs5.50242.

Do Multidisciplinary Team (MDT) processes influence survival in patients with colorectal cancer? A population-based experience.

Munro A, Brown M, Niblock P, Steele R, Carey F BMC Cancer. 2015; 15:686.

PMID: 26463599 PMC: 4604766. DOI: 10.1186/s12885-015-1683-1.

Patterns of Pelvic Radiotherapy in Patients with Stage II/III Rectal Cancer.

Fitzgerald T, Zervos E, Wong J J Cancer Epidemiol. 2013; 2013:408460.

PMID: 24223589 PMC: 3808718. DOI: 10.1155/2013/408460.

References

Bjerkeset T, Edna T . Rectal cancer: the influence of type of operation on local recurrence and survival. Eur J Surg. 1996; 162(8):643-8. View

Marijnen C, Nagtegaal I, Kapiteijn E, Kranenbarg E, Noordijk E, van Krieken J . Radiotherapy does not compensate for positive resection margins in rectal cancer patients: report of a multicenter randomized trial. Int J Radiat Oncol Biol Phys. 2003; 55(5):1311-20. DOI: 10.1016/s0360-3016(02)04291-8. View

Dickman P, Sloggett A, Hills M, Hakulinen T . Regression models for relative survival. Stat Med. 2003; 23(1):51-64. DOI: 10.1002/sim.1597. View

Platell C, Semmens J . Review of survival curves for colorectal cancer. Dis Colon Rectum. 2005; 47(12):2070-5. DOI: 10.1007/s10350-004-0743-4. View

Wibe A, Moller B, Norstein J, Carlsen E, Wiig J, Heald R . A national strategic change in treatment policy for rectal cancer--implementation of total mesorectal excision as routine treatment in Norway. A national audit. Dis Colon Rectum. 2002; 45(7):857-66. DOI: 10.1007/s10350-004-6317-7. View

Wibe A, Carlsen E, Dahl O, Tveit K, Weedon-Fekjaer H, Hestvik U . Nationwide quality assurance of rectal cancer treatment. Colorectal Dis. 2006; 8(3):224-9. DOI: 10.1111/j.1463-1318.2005.00924.x. View

Kwok S, Lau W, Leung K, Liew C, Li A . Prospective analysis of the distal margin of clearance in anterior resection for rectal carcinoma. Br J Surg. 1996; 83(7):969-72. DOI: 10.1002/bjs.1800830726. View

Mezhir J, Smith K, Fichera A, Hart J, Posner M, Hurst R . Presence of distal intramural spread after preoperative combined-modality therapy for adenocarcinoma of the rectum: what is now the appropriate distal resection margin?. Surgery. 2005; 138(4):658-63. DOI: 10.1016/j.surg.2005.06.048. View

Borowski D, Ratcliffe A, Bharathan B, Gunn A, Bradburn D, Mills S . Involvement of surgical trainees in surgery for colorectal cancer and their effect on outcome. Colorectal Dis. 2008; 10(8):837-45. DOI: 10.1111/j.1463-1318.2007.01465.x. View

10.

Nagtegaal I, Marijnen C, Kranenbarg E, van de Velde C, van Krieken J . Circumferential margin involvement is still an important predictor of local recurrence in rectal carcinoma: not one millimeter but two millimeters is the limit. Am J Surg Pathol. 2002; 26(3):350-7. DOI: 10.1097/00000478-200203000-00009. View

11.

Tjandra J, Kilkenny J, Buie W, Hyman N, Simmang C, Anthony T . Practice parameters for the management of rectal cancer (revised). Dis Colon Rectum. 2005; 48(3):411-23. DOI: 10.1007/s10350-004-0937-9. View

12.

Heald R, Moran B, Ryall R, Sexton R, Macfarlane J . Rectal cancer: the Basingstoke experience of total mesorectal excision, 1978-1997. Arch Surg. 1998; 133(8):894-9. DOI: 10.1001/archsurg.133.8.894. View

13.

Bernstein T, Endreseth B, Romundstad P, Wibe A . Circumferential resection margin as a prognostic factor in rectal cancer. Br J Surg. 2009; 96(11):1348-57. DOI: 10.1002/bjs.6739. View

14.

. Adjuvant radiotherapy for rectal cancer: a systematic overview of 8,507 patients from 22 randomised trials. Lancet. 2001; 358(9290):1291-304. DOI: 10.1016/S0140-6736(01)06409-1. View

15.

Ceelen W, Fierens K, van Nieuwenhove Y, Pattyn P . Preoperative chemoradiation versus radiation alone for stage II and III resectable rectal cancer: a systematic review and meta-analysis. Int J Cancer. 2009; 124(12):2966-72. DOI: 10.1002/ijc.24247. View

16.

Wibe A, Rendedal P, Svensson E, Norstein J, Eide T, Myrvold H . Prognostic significance of the circumferential resection margin following total mesorectal excision for rectal cancer. Br J Surg. 2002; 89(3):327-34. DOI: 10.1046/j.0007-1323.2001.02024.x. View

17.

Jorgren F, Johansson R, Damber L, Lindmark G . Oncological outcome after incidental perforation in radical rectal cancer surgery. Int J Colorectal Dis. 2010; 25(6):731-40. DOI: 10.1007/s00384-010-0930-9. View

18.

Quirke P, Durdey P, Dixon M, Williams N . Local recurrence of rectal adenocarcinoma due to inadequate surgical resection. Histopathological study of lateral tumour spread and surgical excision. Lancet. 1986; 2(8514):996-9. DOI: 10.1016/s0140-6736(86)92612-7. View

19.

Eriksen M, Wibe A, Syse A, Haffner J, Wiig J . Inadvertent perforation during rectal cancer resection in Norway. Br J Surg. 2004; 91(2):210-6. DOI: 10.1002/bjs.4390. View

20.

Lydersen S, Fagerland M, Laake P . Recommended tests for association in 2 x 2 tables. Stat Med. 2009; 28(7):1159-75. DOI: 10.1002/sim.3531. View